aflibercept Injection
For Intravitreal Injection Initial U.S. Approval 2011

Facts about aflibercept Injection

Approval Date: 2011
Proprietary Name: On Request
Active Ingredient(s): aflibercept
Dosage Forms And Strengths: 40 mg/mL solution for intravitreal injection in a single-use vial
Company: Regeneron Pharmaceuticals, Bayer
Diseases: wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, macular edema
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “aflibercept Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.